<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01240057</url>
  </required_header>
  <id_info>
    <org_study_id>ML 6277</org_study_id>
    <secondary_id>B32220108118</secondary_id>
    <nct_id>NCT01240057</nct_id>
  </id_info>
  <brief_title>Tracheal Occlusion To Accelerate Lung Growth (TOTAL) Trial for Severe Pulmonary Hypoplasia</brief_title>
  <acronym>TOTAL</acronym>
  <official_title>Randomized Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) Versus Expectant Management During Pregnancy in Fetuses With Left Sided and Isolated Congenital Diaphragma Hernia and Severe Pulmonary Hypoplasia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gasthuisberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King's College Hospital NHS Trust (UK)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Antoine Beclere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mater Mothers' Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Maggiore Policlinico, Milan (IT)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Pediatrico Bambino Ges√π, Rome (IT)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mount Sinai Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Child Health and Development, Tokyo (JP)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas Health Science Center at Houston, TX (US)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>1st Department of Obstetrics and Gynecology, Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Gasthuisberg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial investigates whether prenatal intervention improves survival rate of fetuses with
      isolated congenital diaphragmatic hernia and severe pulmonary hypoplasia, as compared to
      expectant management during pregnancy, both followed by standardized postnatal care.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Actual">March 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival at discharge from neonatal intensive care unit</measure>
    <time_frame>at discharge from neonatal intensive care unit</time_frame>
    <description>The baby can be discharged either alive (and then it qualifies as &quot;surviving at discharge&quot;) or dead. Not discharged babies have not reached the primary endpoint.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>prenatal increase in lung volume</measure>
    <time_frame>2 weeks</time_frame>
    <description>volume of lung after occlusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>grading of oxygen dependency</measure>
    <time_frame>56 days of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of pulmonary hypertension</measure>
    <time_frame>within first weeks of life</time_frame>
    <description>determined by cardiac ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of days in Neonatal Intensive Care Unit (NICU)</measure>
    <time_frame>within hospital stay</time_frame>
    <description>As long as the baby is in the hospital, it is hospitalized either in NICU or in another, less intensive care unit.
The number of days in NICU is an outcome variable, expressed in days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of days on ventilator</measure>
    <time_frame>within NICU stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence of periventricular leucomalacia</measure>
    <time_frame>2 months of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence of neonatal sepsis, intraventricular haemorrhage, retinopathy grade III or higher</measure>
    <time_frame>within hospital stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of days till full enteral feeding</measure>
    <time_frame>within first 2 years of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence of gastro-esophagal reflux</measure>
    <time_frame>at discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>day of surgery</measure>
    <time_frame>within hospital stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>requirement for use of patch for repair</measure>
    <time_frame>at the time of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neurodevelopment at 12 and 24 months</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pulmonary function at one year of age</measure>
    <time_frame>one year of age</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">93</enrollment>
  <condition>Congenital Diseases</condition>
  <condition>Diaphragmatic Hernia</condition>
  <condition>Pulmonary Hypoplasia</condition>
  <arm_group>
    <arm_group_label>expectant management during pregnancy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>watchful waiting during pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fetal endoluminal tracheal occlusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>fetoscopic balloon occlusion at 27 to 30 weeks of gestation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fetal endoluminal tracheal occlusion</intervention_name>
    <description>percutaneous fetoscopy, positioning of endoluminal balloon at 27-30 weeks and whenever possible elective removal at 34 weeks</description>
    <arm_group_label>fetal endoluminal tracheal occlusion</arm_group_label>
    <other_name>Balt Goldbal 2 balloon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>watchful waiting during pregnancy</intervention_name>
    <description>pregnancy surveillance for fetal wellbeing, development of polyhydramnios and cervical shortening</description>
    <arm_group_label>expectant management during pregnancy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18 years or more, who are able to consent

          -  Singleton pregnancy

          -  Anatomically and chromosomally normal fetus

          -  Left sided diaphragmatic hernia

          -  Gestation at randomization prior to 29 wks plus 5 d (so that occlusion is done at the
             latest on 29 wks plus 6 d)

          -  Estimated to have severe pulmonary hypoplasia, defined prenatally as: O/E LHR &lt;25 %,
             irrespective of the liver position

          -  Acceptance of randomization and the consequences for the further management during
             pregnancy and thereafter.

          -  The patients must undertake the responsibility for either remaining close to, or at
             the FETO center, or being able to travel swiftly and within acceptable time interval
             to the FETO center until the balloon is removed.

          -  Intended postnatal treatment center must subscribe to suggested guidelines for
             &quot;standardized postnatal treatment&quot;.

          -  Provide written consent to participate in this RCT

        Exclusion Criteria:

          -  Maternal contraindication to fetoscopic surgery or severe medical condition in
             pregnancy that make fetal intervention risk full

          -  Technical limitations precluding fetoscopic surgery, such as severe maternal obesity,
             uterine fibroids or potentially others, not anticipated at the time of writing this
             protocol.

          -  Preterm labour, cervix shortened (&lt;15 mm at randomization) or uterine anomaly strongly
             predisposing to preterm labour, placenta previa

          -  Patient age less than 18 years

          -  Psychosocial ineligibility, precluding consent

          -  Diaphragmatic hernia: right-sided or bilateral, major anomalies, isolated left-sided
             outside the O/E LHR limits for the inclusion criteria

          -  Patient refusing randomization or to comply with return to FETO center during the time
             period the airways are occluded or for elective removal of the balloon
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Deprest, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mater Mother's Hospital</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H√¥pital Antoine B√©cl√®re</name>
      <address>
        <city>Clamart</city>
        <zip>92141</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Pediatrico Bambino Ges√π</name>
      <address>
        <city>Rome</city>
        <zip>00123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Center for Child Health and Development</name>
      <address>
        <city>Tokyo</city>
        <zip>157-8535</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>1st Department of Obstetrics and Gynecology, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic Barcelona</name>
      <address>
        <city>Barcelona</city>
        <state>Catalunya</state>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.totaltrial.eu</url>
    <description>opens only end 2010</description>
  </link>
  <reference>
    <citation>Jani JC, Nicolaides KH, Gratac√≥s E, Valencia CM, Don√© E, Martinez JM, Gucciardo L, Cruz R, Deprest JA. Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 2009 Sep;34(3):304-10. doi: 10.1002/uog.6450.</citation>
    <PMID>19658113</PMID>
  </reference>
  <reference>
    <citation>Deprest J, Breysem L, Gratacos E, Nicolaides K, Claus F, Debeer A, Smet MH, Proesmans M, Fayoux P, Storme L. Tracheal side effects following fetal endoscopic tracheal occlusion for severe congenital diaphragmatic hernia. Pediatr Radiol. 2010 May;40(5):670-3. doi: 10.1007/s00247-010-1579-9. Epub 2010 Mar 30.</citation>
    <PMID>20352401</PMID>
  </reference>
  <reference>
    <citation>Deprest JA, Gratacos E, Nicolaides K, Done E, Van Mieghem T, Gucciardo L, Claus F, Debeer A, Allegaert K, Reiss I, Tibboel D. Changing perspectives on the perinatal management of isolated congenital diaphragmatic hernia in Europe. Clin Perinatol. 2009 Jun;36(2):329-47, ix. doi: 10.1016/j.clp.2009.03.004. Review.</citation>
    <PMID>19559323</PMID>
  </reference>
  <reference>
    <citation>Deprest JA, Hyett JA, Flake AW, Nicolaides K, Gratacos E. Current controversies in prenatal diagnosis 4: Should fetal surgery be done in all cases of severe diaphragmatic hernia? Prenat Diagn. 2009 Jan;29(1):15-9. doi: 10.1002/pd.2108.</citation>
    <PMID>19125386</PMID>
  </reference>
  <reference>
    <citation>Deprest JA, Flemmer AW, Gratacos E, Nicolaides K. Antenatal prediction of lung volume and in-utero treatment by fetal endoscopic tracheal occlusion in severe isolated congenital diaphragmatic hernia. Semin Fetal Neonatal Med. 2009 Feb;14(1):8-13. doi: 10.1016/j.siny.2008.08.010. Epub 2008 Oct 8.</citation>
    <PMID>18845492</PMID>
  </reference>
  <reference>
    <citation>Jani JC, Benachi A, Nicolaides KH, Allegaert K, Gratac√≥s E, Mazkereth R, Matis J, Tibboel D, Van Heijst A, Storme L, Rousseau V, Greenough A, Deprest JA; Antenatal-CDH-Registry group. Prenatal prediction of neonatal morbidity in survivors with congenital diaphragmatic hernia: a multicenter study. Ultrasound Obstet Gynecol. 2009 Jan;33(1):64-9. doi: 10.1002/uog.6141.</citation>
    <PMID>18844275</PMID>
  </reference>
  <reference>
    <citation>Jani J, Nicolaides KH, Keller RL, Benachi A, Peralta CF, Favre R, Moreno O, Tibboel D, Lipitz S, Eggink A, Vaast P, Allegaert K, Harrison M, Deprest J; Antenatal-CDH-Registry Group. Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia. Ultrasound Obstet Gynecol. 2007 Jul;30(1):67-71.</citation>
    <PMID>17587219</PMID>
  </reference>
  <reference>
    <citation>Jani J, Keller RL, Benachi A, Nicolaides KH, Favre R, Gratacos E, Laudy J, Eisenberg V, Eggink A, Vaast P, Deprest J; Antenatal-CDH-Registry Group. Prenatal prediction of survival in isolated left-sided diaphragmatic hernia. Ultrasound Obstet Gynecol. 2006 Jan;27(1):18-22.</citation>
    <PMID>16374756</PMID>
  </reference>
  <reference>
    <citation>Deprest J, Gratacos E, Nicolaides KH; FETO Task Group. Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: evolution of a technique and preliminary results. Ultrasound Obstet Gynecol. 2004 Aug;24(2):121-6. Erratum in: Ultrasound Obstet Gynecol. 2004 Oct;24(5):594.</citation>
    <PMID>15287047</PMID>
  </reference>
  <reference>
    <citation>Rodrigues HC, Deprest J, v d Berg PP. When referring physicians and researchers disagree on equipoise: the TOTAL trial experience. Prenat Diagn. 2011 Jun;31(6):589-94. doi: 10.1002/pd.2756. Epub 2011 Apr 11.</citation>
    <PMID>21484841</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 4, 2010</study_first_submitted>
  <study_first_submitted_qc>November 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2010</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gasthuisberg</investigator_affiliation>
    <investigator_full_name>Jan Deprest</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Isolated Congenital Diaphragmatic Hernia</keyword>
  <keyword>Fetal Surgery</keyword>
  <keyword>Pulmonary Hypoplasia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernias, Diaphragmatic, Congenital</mesh_term>
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Diaphragmatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

